A Phase 1 interventional study of Calcium and Potassium in Hypertension, sponsored by Erling Bjerregaard Pedersen. Completed at 1 site in Denmark. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-21.
Sponsored by Erling Bjerregaard Pedersen · Phase 1, Interventional, and Treatment
In humans living of fruit and vegetables, hypertension is rarely seen. We wish to study if the development of hypertension has a connection to our intake of potassium. We know that fruit and vegetables contain a lot of potassium and we will simulate this intake by giving healthy subjects potassium as tablets.
6,687 studies on the registry are indexed under Hypertension; 964 are open to participants now.
This study's enrollment of 25 is below the median of 90 across 4,994 interventional studies indexed under Hypertension.
Browse Hypertension studies →Erling Bjerregaard Pedersen is the lead sponsor of 16 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Calcium tablets
Drug: Calcium
Potassium tablets
Drug: Potassium
tablets, 1 tablet 2 times per day in 28 days
Tablets, 5 tablets 2 times per day for 28 days
Effect on blood pressure
Time frame: three months
This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Erling Bjerregaard Pedersen